Search

Search Constraints

You searched for: Author/Creator Chirehwa, Maxwell

Search Results

4. Early antituberculosis drug exposure in hospitalized patients with human immunodeficiency virus‐associated tuberculosis. Issue 5 (17th February 2020)

5. Effect of genetic variation in UGT1A and ABCB1 on moxifloxacin pharmacokinetics in South African patients with tuberculosis. (January 2018)

6. Effect of rifampicin and efavirenz on moxifloxacin concentrations when co-administered in patients with drug-susceptible TB. (8th February 2017)

7. Effects of genetic variability on rifampicin and isoniazid pharmacokinetics in South African patients with recurrent tuberculosis. (15th February 2019)

9. Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis. (April 2021)

10. Pharmacokinetics of First-Line Drugs in Children With Tuberculosis, Using World Health Organization–Recommended Weight Band Doses and Formulations. (22nd August 2021)